Showing posts with label neuroplasticity on demand. Show all posts
Showing posts with label neuroplasticity on demand. Show all posts
Thursday, August 13, 2026
Tuesday, August 4, 2026
Neuroplasticity After Stroke: Clinical Evidence and Its Implication for Effective Rehabilitation Strategies
You're NOT SOLVING THE PROBLEM! You're all fired for incompetence! How do you make neuroplasticity repeatable on demand?
Neuroplasticity After Stroke: Clinical Evidence and Its Implication for Effective Rehabilitation Strategies
Abstract
Stroke remains a major cause of long-term disability as it often leads to persistent motor deficits, which hinder functional recovery. Neuroplasticity is an important driver of poststroke recovery as it supports synaptic remodeling, network reorganization, and activity-dependent adaptation. This review outlines the neurobiological mechanisms of recovery, including Hebbian and homeostatic plasticity. It also discusses how intensive, task-specific rehabilitation leverages these processes. Technological innovations, such as robotic-assisted rehabilitation and sensor-based feedback, further enable high-dose, repetitive, and personalized training. In addition, adjunctive strategies, including pharmacological modulation, noninvasive brain stimulation, and stem cell therapies, which aim to enhance neuroplasticity, are highlighted. Despite their promise, these interventions show inconsistent efficacy, indicating the need for individualized approaches tailored to lesion characteristics, neurophysiological markers, and recovery stage. Future directions should emphasize the integration of biomarkers, neuroimaging, and precision neurotechnologies, together with multimodal combination therapies. These efforts are essential to establish adaptive rehabilitation protocols that can enhance both the consistency and the magnitude of functional recovery.
Highlights
• Neuroplasticity is essential to poststroke recovery and functional restoration.
• Intensive rehabilitation is an important element of experience-dependent plasticity.
• Multimodal therapies enhance recovery outcome but require individualized approaches.
More at link.
Friday, July 31, 2026
Ketamine Reshapes Neural Networks and Neuroplasticity
In female mice, so you'll have to contact your competent? doctor to get human testing going. Make sure you can get protocols for neuroplasticity on demand!
Ketamine Reshapes Neural Networks and Neuroplasticity
Summary: Researchers discovered a sex-specific mechanism through which ketamine induces neuroplasticity in female mice.
During recovery from ketamine anesthesia, female mice experience a spike in circulating corticosterone, triggering microglia, the brain’s resident immune cells, to upregulate the Fkbp5 gene and produce the FKBP51 protein. This pathway activates microglia to extend processes, intermingle with adjacent neurons, and strip away sections of the extracellular matrix.
The degradation of this structural support creates space for synaptic remodeling and network reorganization. This microglial remodeling pathway was entirely absent in male mice, highlighting distinct neuroimmune responses between sexes and providing a novel molecular target for regulating neuroplasticity and optimizing depression treatments.
Key Facts
- Sex-Differentiated Microglial Activation: Microglial processes extend and intermingle with surrounding neurons during ketamine recovery specifically in female mice, a behavior not observed in male counterparts.
- Extracellular Matrix Degradation: Activated female microglia degrade and remove components of the extracellular matrix, breaking down structural barriers to allow the formation of new synaptic connections.
- Endocrine-Immune Signaling Cascade: The underlying pathway relies on a surge of systemic corticosterone during recovery, which activates microglial Fkbp5 gene expression to yield the functional FKBP51 protein.
- Single-Nucleus Transcriptomics: Single-nucleus RNA sequencing conducted by the Allen Institute isolated the precise cellular populations and transcriptomic changes that differentiate male and female microglial responses to ketamine.
- Therapeutic Implications: Demonstrates that FKBP51 acts as an inducible lever for controlling structural neuroplasticity, underscoring the critical need to account for biological sex in drug efficacy testing for major depressive disorder and neuropsychiatric conditions.
Source: Allen Institute
Doctors use ketamine on patients as general anesthesia before surgery. They also prescribe it in low doses for pain management, and more recently, it’s been used for treatment-resistant depression where other drugs have failed. It works by dampening communication between brain cells.
But a new study reveals that its effects on the brain are different in male and female mice. This insight—if reproduced in humans—could change the way we test the efficacy of drugs and unlock better treatments for depression.
Researchers at the Institute of Science and Technology Austria, in collaboration with scientists at the Allen Institute, discovered that when female mice are recovering from a single ketamine sedation, their brains become much more active than their male counterparts, specifically their microglia. These specialized brain cells began reaching out with their branch-like arms to intermingle with surrounding brain cells.
This increased activity led to the removal of the extracellular matrix—the proteins and molecules surrounding, supporting, and giving structure to cells—and created space that allowed new synapses to form and remodel the neural network, thereby increasing neuroplasticity. Researchers didn’t observe this behavior in male mice.
“We didn’t expect to see this; it was a surprising finding,” said Sandra Siegert, professor at the Institute of Science and Technology Austria and senior author of the study. Microglia are the brain’s defense system—immune cells that help clear debris, trigger inflammation to protect the brain, and maintain optimal brain function.
A pathway to neuroplasticity
Importantly, scientists uncovered the precise pathway of this increased neuroplasticity: during recovery from ketamine anesthesia, corticosterone spiked in the blood. Corticosterone is an important hormone that helps animals respond to stress. This hormone triggered microglia to turn on the Fkbp5 gene, which then produces the FKBP51 protein.
This protein in turn activated the microglia to start intermingling with surrounding neurons, which eventually led to an increase in neuroplasticity. Scientists at the Allen Institute performed single-nucleus RNA sequencing to help uncover this hidden pathway and reveal the specific gene that was turned on in female mice but not in males.
Neuroplasticity is a delicate balance: too much or too little has both been linked to neuropsychiatric disorders. “Understanding how to balance good plasticity versus maladaptive plasticity is very important for healthy life, healthy aging, and neuropsychiatric diseases,” said Bosiljka Tasic, Director of Molecular Genetics at the Allen Institute and one of the study co-authors.
“How can you modify and modulate this plasticity but in a positive way? Many of the major plasticity-inducing drugs have become quite interesting, especially as treatments for depression, but we still don’t know how they work.”
The new research reveals that at least in female mice, the FKBP51 protein can be a lever to pull in order to regulate neuroplasticity in the brain, and that ketamine can be one way to pull this lever. The findings, if fully replicated in humans, point to the importance of sex differences when evaluating the effects of drugs and treatments. “How drug effects differ between males and females is important to know in order to offer the best treatment,” said Siegert.
In immunology, it is known that immune cells respond differently between males and females, which can lead to different outcomes in infectious diseases. “Microglia, which have capabilities similar to macrophages, are not necessarily excluded from this assumption,” said Siegert. “It is only now that scientists are exploring this topic.”
Key Questions Answered:
Q: How does ketamine increase neuroplasticity in female mice according to this study?
A: Ketamine recovery causes a spike in corticosterone, which activates the Fkbp5 gene in female microglia. The resulting FKBP51 protein prompts microglia to reach into surrounding neural tissue and clear away portions of the extracellular matrix, creating physical space for new synapses to form and reorganize the neural network.
Q: Did male mice exhibit the same brain-remodeling reaction to ketamine?
A: No. The corticosterone-driven FKBP51 microglial activation and subsequent degradation of the extracellular matrix were uniquely observed in female mice, demonstrating a distinct sex-specific neuroimmune response to ketamine sedation.
Q: What clinical significance do these findings hold for depression treatment?
A: Because neuroplasticity is central to ketamine’s antidepressant effects, identifying the FKBP51 pathway reveals a potential molecular target to modulate therapeutic plasticity. It also highlights that psychiatric medications can operate via fundamentally different biological mechanisms in males and females, requiring sex-tailored drug design and evaluation.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this neuroscience and neuroplasticity research news
Author: Peter Kim
Source: Allen Institute
Contact: Peter Kim – Allen Institute
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Corticosterone-linked microglial activity underpins sexually dimorphic neuroplasticity after ketamine anesthesia”
by Alessandro Venturino, MohammadAmin Alamalhoda, Thomas Negrello,
Kelly Jin, Cindy T. J. van Velthoven, Ryan John A. Cubero, Jake Yeung,
Peter Koppensteiner, Bosiljka Tasic, Sandra Siegert. Science Advances
DOI:10.1126/sciadv.adz6517
Monday, July 27, 2026
ECT Reprograms Adult Neurons into a Youthful State
Have your competent? doctor and hospital initiate research/human testing that finishes the job and delivers 100% recovery protocols! Why can't that be done?
Laziness? Incompetence? Or just don't care? NO leadership? NO strategy? Not my job? Not my Problem!
And your board of directors is so incompetent they don't recognize incompetence in their staff!
ECT Reprograms Adult Neurons into a Youthful State
Summary: Researchers engineered a highly specialized patterned stimulation protocol called REPOPS (Repeated Electroconvulsive-like Patterned Optical/Electrical Stimulation) in murine models to precisely mirror the neural activation patterns of ECT. The empirical data unmasked a stunning structural transformation: intensive ECT-like stimulation coaxes fully mature, non-dividing adult neurons to undergo an active process of cellular dematuration.
By entering a state of nuclear reprogramming driven unexpectedly by the cell-cycle protein Cyclin B, mature neurons fundamentally reshape their identity, winding back their genetic clocks to resemble highly plastic, early postnatal developmental states.
Key Facts
- The Cellular Dematuration Framework: Genome-wide transcriptomic profiling unmasked that REPOPS forces mature, fully differentiated adult neurons to suppress their adult genetic markers. Instead, they reactivate gene expression blueprints that match early postnatal development. Widespread genome-wide chromatin mapping confirmed long-lasting structural changes in chromatin accessibility, proving this youthful state is epigentically locked in place for over a month.
- Unexpected Post-Mitotic Cell Cycle Re-entry: The most jaw-dropping molecular discovery was that adult neurons, cells that are strictly post-mitotic and can never divide again, suddenly expressed gene networks typically reserved exclusively for the G2/M division phase of proliferating cells. The neurons displayed clear physical hallmarks of mitosis, including widespread histone phosphorylation, the breakdown of the nuclear lamina protective skin, and pronounced chromatin condensation.
- Cyclin B Isolated as the Molecular Driver: To prove this cell-cycle activation was driving the structural shift rather than acting as a random byproduct, Miyakawa’s lab deployed targeted genome-editing technology. Mice engineered to lack Cyclin B (the core molecular key required to cross the G2/M phase boundary) exhibited a total failure of nuclear reprogramming and showed zero behavioral improvements following stimulation, identifying Cyclin B as the absolute gatekeeper of ECT efficacy.
- The “Intermediate State” of Heightened Plasticity: Calcium-flux live imaging in actively behaving mice revealed that REPOPS does not simply act as an on/off switch for neural circuits. Instead, it coaxes the brain into a unique “intermediate state” of intense plasticity. The network completely shifted how it encoded information, selectively suppressing spatial coding maps while heavily boosting speed-related navigation tracking for over two weeks.
- Human Validation in the Dentate Gyrus: Transitioning from mice to humans, the team’s reanalysis of postmortem brain tissue from deceased patients with major depression revealed an identical biological footprint. Individuals who had undergone ECT treatments prior to their passing displayed the exact same immature-like gene expression patterns within the dentate gyrus (the primary gateway of the hippocampus) compared to non-ECT patients, confirming human translation.
- A Double-Edged Sword for Neurology: Professor Miyakawa emphasizes that this newly uncovered intermediate state is a powerful, highly flexible biological tool. While this extreme boost in structural plasticity is precisely what allows an injured brain to break free from severe depression, the team warns that if the exact same nuclear reprogramming occurs under incorrect or overly aggressive conditions (such as advanced neurodegeneration or epilepsy), it could spin out of control and drive severe pathology.
- Source: Fujita Health University
Nearly 90 years after Ugo Cerletti and Lucio Bini introduced electroconvulsive therapy (ECT), brain stimulation therapies such as ECT and Repetitive Transcranial Magnetic Stimulation (rTMS) are common in psychiatry because they are highly effective for treating depression and schizophrenia, yet their cellular mechanisms remain poorly understood.
The team introduced REPOPS, a form of patterned stimulation in mice designed to mimic key features of ECT-like neuronal activation.
Mice subjected to REPOPS showed increased locomotor activity and reduced depression-like behavior, revealing stimulation-induced lasting behavioral changes similar to ECT-like states. At the cellular level, the stimulation induced a state of cellular dematuration, in which adult neurons had gene expression patterns resembling those seen in early postnatal development.
Stimulation for three days caused only transient changes, while ten-day stimulation resulted in a stable dematuration state that persisted for over a month. Genome-wide chromatin mapping revealed widespread and persistent changes in chromatin accessibility, providing molecular evidence for the durability of this state.
A reanalysis of postmortem brain RNA-seq data from patients with mood disorders showed that ECT-treated individuals exhibited a similar immature-like gene expression pattern in the dentate gyrus compared to non-ECT-treated patients, suggesting that similar immature-like changes may also occur in the human dentate gyrus after ECT.
Surprising Emergence of Cell Cycle Re-entry in Mature Neurons
A gene expression analysis revealed an unexpected finding: despite being post-mitotic (cells that no longer divide), neurons following REPOPS exhibited gene expression patterns characteristic of the G2/M phase of the cell cycle in dividing cells, accompanied by nuclear hallmarks of mitosis — histone phosphorylation, disruption of the nuclear lamina, and chromatin condensation.
These molecular and structural changes suggested nuclear reprogramming. Using genome-editing technology, the researchers demonstrated that mice lacking Cyclin B, a key molecular regulator of the G2/M phase transition, showed less nuclear reprogramming and behavioral changes, identifying it as a driver of cellular state triggered by neuronal stimulation.
An Intermediate State of Heightened Plasticity
The researchers next asked how nuclear reprogramming affects neuronal function. They used microscopic imaging of calcium fluxes, a proxy for neuronal activity, in behaving mice. Curiously, REPOPS did not simply turn neuronal activity on or off. Instead, it produced a patterned shift in how neurons encode different types of information — spatial coding was suppressed while speed-related coding was enhanced — that persisted for over two weeks.
Taken together, these molecular, nuclear structural, and functional findings led the researchers to propose that the dematured cellular state induced by ECT-like stimulation represents an “intermediate state” of high plasticity — neither the normal mature state nor the fully immature one — where the specific configuration may depend on how strongly, how often, and under what conditions neuronal activity is applied. The plasticity supporting therapeutic effects in depression could, under different conditions such as epilepsy or neurodegeneration, contribute to pathology instead.
“Nuclear reprogramming — the ability of neurons to fundamentally reshape their own identity — is a candidate mechanism we had not previously considered,” said Prof. Miyakawa. “These findings provide a new cellular framework for thinking about how durable changes in neural function can arise, and they offer a potential route to improved therapies.”
Key Questions Answered:
Q: How can a cell that is “post-mitotic” start using cell-cycle genes without turning into a tumor or dividing?
A: This is what makes Professor Miyakawa’s discovery an absolute shock to traditional biology. For decades, neuroscience has taught that once a neuron reaches maturity, it becomes permanently post-mitotic, meaning it locks its cell-division machinery away forever. If a mature neuron attempts to force its way through cell division, it typically triggers immediate cell death. The REPOPS framework proves that neurons can cleverly hijack the early stages of this division machinery (the G2/M phase) without actually completing the physical split. They use proteins like Cyclin B to intentionally soften their internal structure, break down their nuclear lining, and loosen up their packed DNA. They aren’t trying to duplicate; they are using the tools of cell division to perform a massive, structural house clean, allowing them to rapidly rewrite their active genes.
Q: What is “cellular dematuration,” and why does winding back a neuron’s clock cure severe depression?
A: Think of severe, chronic depression like a deep, frozen rut in a muddy road. Over months or years of illness, the adult brain’s neural connections become incredibly rigid, locking negative emotional paths in place. “Cellular dematuration” is the biological equivalent of melting that frozen mud back into soft clay. By forcing adult neurons to temporarily express genes that look exactly like those found in a newborn baby’s brain, ECT-like stimulation strips away this unhealthy structural rigidity. The neuron doesn’t lose its long-term identity, but it enters an open, highly sensitive “intermediate state” of intense plasticity. This sudden malleability gives the brain a vital window to wipe away the rigid, depressive neural ruts and wire up entirely new, healthy pathways.
Q: If this treatment induces such massive brain changes, why don’t patients lose all their memories or cognitive function?
A: The live calcium-flux imaging in behaving models provided a fascinating answer to this concern. The treatment does not act like a chaotic eraser that turns off neural signaling across the board. Instead, entering this high-plasticity intermediate state causes the brain to elegantly pivot how it processes information. For instance, the researchers observed that while the neurons temporarily suppressed their spatial layout maps, they simultaneously cranked up their sensitivity to tracking speed. The brain remains active and functional, but its processing modes are temporarily shifted. Because the study showed these changes spontaneously stabilize and return to an adult baseline after a month, it confirms that the brain undergoes a structured, temporary transition rather than permanent damage.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this neuroscience research news
Author: Hisatsugu Koshimizu
Source: Fujita Health University
Contact: Hisatsugu Koshimizu – Fujita Health University
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Repetitive Neuronal Activation Regulates Cellular Maturation State via Nuclear Reprogramming” by Tomoyuki Murano, Hideo Hagihara, Katsunori Tajinda, Keizo Takao, Yoshihiro Takamiya, Kaoru Katoh, Alfred J. Robison, Mitsuyuki Matsumoto, Masakazu Namihira & Tsuyoshi Miyakawa. Nature Communications
DOI:10.1038/s41467-026-74202-w
Friday, July 24, 2026
Engineers Redefined Light Delivery to Track Neural Firing
Now your competent? doctor can get research going that captures the signals sent by one neuron to a neighbor to drop their current task and take on theirs. Figuring that out could finally make neuroplasticity repeatable on demand,
Engineers Redefined Light Delivery to Track Neural Firing
Summary: Researchers developed a two-photon imaging platform called FlatMux that captures real-time electrical voltage signals from nearly 200 neurons simultaneously in living brain tissue.
The team redesigned optical light delivery to overcome physical trade-offs between laser power, tissue heating, and signal sensitivity. By using an optical cavity to split laser beams into precisely timed pulses without mechanical raster sweeping, FlatMux maximizes fluorescence photon efficiency while reaching frame rates up to 2,000 frames per second at depths of 500 micrometers.
The system detects genetically encoded voltage indicators (GEVIs) with millisecond precision across multiple cortical layers, successfully capturing sub-threshold synaptic signals. This technology allows neuroscientists to map functional connectivity and observe parallel computation across distributed neural networks as animals engage in sensory behavior.
Key Facts
- Unprecedented Speed and Scale: FlatMux records direct electrical activity from nearly 200 neurons simultaneously across single or multiple cortical layers at frame rates up to 2,000 Hz.
- Deep Tissue Penetration: The platform captures millisecond voltage signals up to 500 micrometers deep in scattering cortical tissue of awake, head-fixed mice.
- Efficient Optical Cavity Engineering: Instead of traditional mechanical laser sweeping, FlatMux splits a laser beam into non-overlapping pulses delivered at 150 million samples per second, minimizing tissue heating while maximizing photon yield per neuron.
- Sub-Threshold Signal Detection: In high-sensitivity mode, FlatMux detects faint voltage fluctuations that precede action potentials, enabling optical mapping of synaptically connected, functional microcircuits.
- Cell Type Identification: Direct voltage imaging via fluorescent signals allows researchers to simultaneously identify physical cell locations, cell-type classifications, and real-time functional roles without physical electrode insertion.
Source: Rockefeller University
The brain is a vast, densely interconnected network of neurons computing in parallel. Watching these computations unfold in real time could reveal how the brain processes sensation and guides behavior. But the electrical signals governing the network are fast, faint, and notoriously hard to capture in living tissue.
Now, a new study published in Nature Methods describes a two-photon imaging platform that captures electrical activity from almost 200 neurons at once, across cortical layers and at unprecedented depths and speeds, opening a window onto how information moves through living brain circuits.
By minimizing the amount energy needed to reliably detect the activity of a single neuron and devising a scalable strategy to optically scan laser pulses across the sample at a rate of 150 million samples per second, the platform, dubbed FlatMux, sets new benchmarks in the field, enabling recordings from nearly 200 neurons within one or several planes at once, at depths up to 500 micrometers, and at frame rates of up to 2,000 per second.
With both the sensitivity and the speed that this tool offers, researchers can now begin mapping neurons that are functionally connected to and causally interact with one another, enabling a new understanding of how the brain’s wiring and function are giving raise to brain’s cognitive capabilities. Moreover, unlike methods using electrode probes, the direct imaging of electrical activity via fluorescence allows for simultaneous inference of the location and the cell types of recorded neurons.
“For a long time the field has been focused to understand the brain in terms of response properties of individual neuron. Our imaging platform makes it possible to instead investigate how various brain functions could be the result of information processing by a highly interconnected system where computation is distributed across large network of neurons,” says Alipasha Vaziri, head of the Laboratory of Neurotechnology and Biophysics at Rockefeller.
Densely interconnected
Existing imaging tools have been hampered by different limitations. As far as optical tools are concerned, when trying to capture the densely interconnected system of brain cells, scientists long relied on calcium imaging, which uses fluorescent sensors to track calcium surges associated with neurons firing. But calcium signals are only an indirect measurement of electrical activity.
In addition, they are much slower than the millisecond electrical impulses that brain cells use to communicate, so these techniques would miss key features of neural computation, including the signals that shape activity before a neuron fires (so-called sub-threshold responses).
In more recent years, researchers turned instead to genetically encoded voltage indicators, or GEVIs—fluorescent sensors embedded in cell membranes that report voltage directly. But GEVIs have their own challenges. Their signals are faint, about 100 times faster than calcium signals and notoriously difficult to capture deep in living brain tissue.
Imaging them at depth requires two-photon microscopy, a laser-based technique that can peer into scattering tissue but brings its own hard physical limits: too little laser power produces unusable signals, while too much can heat tissue or destroy sensors. Traditional two-photon systems are also highly inefficient in how they deliver light, limiting how many neurons can be recorded and for how long.
Vaziri set out to overcome such limitations, devising a tool that better capture the complex nature of brain activity. “We needed to come up with a system that makes excitation as efficient as it can be,” Vaziri says. “By maximizing the fluorescent photons we get out for the excitation photons we put in, we are able to look at as many neurons as possible.”
Rethinking light
To accomplish this, Vaziri and colleagues would need to rethink light delivery itself. They built a custom two-photon imaging platform, called FlatMux, that utilizes an optical cavity. The new platform splits a laser beam into many precisely timed pulses, which are delivered to series of distinct, non-overlapping points in the tissue in a highly coordinated way.
This is in contrast to the traditional approaches that rely on a mechanically sweeping that results in laser pulses oversampling each sample region during a scan. Their approach does not only allow for faster scanning but also makes the system far more efficient, generating stronger signals from less light, while also reducing tissue heating and undesirable artefacts.
With FlatMux, researchers can image larger groups of neurons, deeper in the brain, and fast enough to capture the millisecond electrical events neurons use to communicate. Moreover, the design of the system is scalable, i.e. as GEVIs continue to improve FlatMux will be able to reallocate realized gains in energetic recourses to record from even larger neuronal populations while maintaining the same speed and without further increases in power.
The team then paired FlatMux with custom computational tools designed to distinguish true neural activity from background noise. Together, the hardware and software work as a single platform: one maximizes how much information can be extracted from every photon sent into the brain, while the other reconstructs the fleeting electrical signals hidden in that data.
Then, to test it in realistic conditions, the team used the system in awake mice running on a treadmill who were exposed to whisker stimulation, showing that the system could capture faint voltage signals during such stimulation as well as during spontaneous behavior.
The result was a system built not just to image more neurons, but to capture neural computation in action. And the payoff was dramatic. FlatMux recorded almost 200 neurons simultaneously, reached depths of 500 micrometers, captured activity at up to 2,000 frames per second, and even imaged two cortical layers at once, allowing researchers to watch signals move through the layered cortical circuitry in real time.
In a high-sensitivity mode, the system also detected signals too weak to trigger firing but critical for revealing the neurons that are synaptically coupled to one another, raising the possibility of mapping functional connections optically and in a high-throughput manner rather than one cell pair at a time.
With FlatMux, it may finally be possible to move beyond snapshots of isolated neurons to capturing computations as they unfold across distributed networks in real time. That could help researchers trace how signals move through circuits, study the coordinated activity underlying various behaviors such as decision-making, and potentially even transform the burgeoning field of connectomics. Its millisecond precision may also help researchers distinguish different kinds of brain cells by their electrical signatures, opening a new way to classify cell types by function.
“A lot of effort has been put into the goal of understanding the brain wiring diagrams of model organisms,” Vaziri says. “The FlatMux platform could be used to infer how neurons are synaptically connected.”
More broadly, FlatMux points toward a shift in neuroscience, from sampling fragments of activity to capturing how living brain circuits compute in real time. “The brain as not only a biological organ but also an information processing system, and I’ve always been excited about figuring out its underlying computational principles,” Vaziri says.
“When we build these kinds of tools, it’s not just about overcoming an engineering challenge. It’s about enabling neuroscience to ask deeper questions about how the brain computes.”
Key Questions Answered:
Q: Why is voltage imaging harder to perform than calcium imaging?
A: Calcium signals are slow, indirect surrogates for neural firing that unfold over hundreds of milliseconds. Direct voltage signals happen in 1 to 2 milliseconds, requiring recording speeds roughly 100 times faster. Furthermore, genetically encoded voltage indicators (GEVIs) yield fainter fluorescent signals, making deep-tissue detection exceptionally difficult without burning brain tissue.
Q: How does FlatMux overcome tissue heating caused by high-power lasers?
A: Traditional two-photon microscopes use mechanical mirrors that sweep lasers across tissue, oversampling regions and dumping excess energy that can heat tissue. FlatMux utilizes a custom optical cavity to split laser pulses into discrete, non-overlapping points in a coordinated sequence, getting the maximum number of fluorescent photons back for every excitation photon sent in.
Q: What is sub-threshold voltage detection and why does it matter?
A: Sub-threshold responses are tiny electrical fluctuations in a neuron that occur before it reaches the threshold required to fire an action potential. Detecting sub-threshold signals reveals how input signals are integrated across synaptically connected neurons, shedding light on functional circuit wiring.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this neurotech research news
Author: Katherine Fenz
Source: Rockefeller University
Contact: Katherine Fenz – Rockefeller University
Image: The image is credited to Neuroscience News
Original Research: Open access.
“A versatile platform for two-photon neuronal population voltage imaging across cortical depths” by Jingkun Guo, Kevin Barber, M. Agustina Frechou, Sihao Lu, Jeff Demas, David Chen, Shuyuan Yang, Alex James McDonald, Michelle Ann Land, François St-Pierre & Alipasha Vaziri. Nature Methods
DOI:10.1038/s41592-026-03158-y
Subscribe to:
Posts (Atom)